In recognition of the fact that Marketing Authorisations for the same VMP in different Member States may require different withdrawal periods, and that MAHs may be in possession of data relating to residues not available at the time the MA was issued, the ANMV has initiated a procedure of updating and harmonising withdrawal periods for similar VMPs.
This exercise will initially focus on VMPs used for treatment of groups of animals, having a short withdrawal period for milk. The review began in July 2014, and the first stage should be completed in the first quarter of 2015 for these priority products. Originator products will be re-evaluated first, and generics of these will be brought into line with them in terms of revised recommendations. Read the full article here (French language only).